Matt Huang said he was led to believe that Alameda Research was not being provided any special treatment by FTX.
* First published on ccn.com
SBF was ‘very resistant’ to investors on FTX board: Paradigm co-founder
Matt Huang said he was led to believe that Alameda Research was not being provided any special treatment by FTX.
* First published on ccn.com